Literature DB >> 22447931

Megakaryocytes regulate expression of Pyk2 isoforms and caspase-mediated cleavage of actin in osteoblasts.

Melissa A Kacena1, Pierre P Eleniste, Ying-Hua Cheng, Su Huang, Mahesh Shivanna, Tomas E Meijome, Lindsey D Mayo, Angela Bruzzaniti.   

Abstract

The proliferation and differentiation of osteoblast (OB) precursors are essential for elaborating the bone-forming activity of mature OBs. However, the mechanisms regulating OB proliferation and function are largely unknown. We reported that OB proliferation is enhanced by megakaryocytes (MKs) via a process that is regulated in part by integrin signaling. The tyrosine kinase Pyk2 has been shown to regulate cell proliferation and survival in a variety of cells. Pyk2 is also activated by integrin signaling and regulates actin remodeling in bone-resorbing osteoclasts. In this study, we examined the role of Pyk2 and actin in the MK-mediated increase in OB proliferation. Calvarial OBs were cultured in the presence of MKs for various times, and Pyk2 signaling cascades in OBs were examined by Western blotting, subcellular fractionation, and microscopy. We found that MKs regulate the temporal expression of Pyk2 and its subcellular localization. We also found that MKs regulate the expression of two alternatively spliced isoforms of Pyk2 in OBs, which may regulate OB differentiation and proliferation. MKs also induced cytoskeletal reorganization in OBs, which was associated with the caspase-mediated cleavage of actin, an increase in focal adhesions, and the formation of apical membrane ruffles. Moreover, BrdU incorporation in MK-stimulated OBs was blocked by the actin-polymerizing agent, jasplakinolide. Collectively, our studies reveal that Pyk2 and actin play an important role in MK-regulated signaling cascades that control OB proliferation and may be important for therapeutic interventions aimed at increasing bone formation in metabolic diseases of the skeleton.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22447931      PMCID: PMC3366857          DOI: 10.1074/jbc.M111.309880

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

1.  Homing efficiency, cell cycle kinetics, and survival of quiescent and cycling human CD34(+) cells transplanted into conditioned NOD/SCID recipients.

Authors:  Anna Jetmore; P Artur Plett; Xia Tong; Frances M Wolber; Robert Breese; Rafat Abonour; Christie M Orschell-Traycoff; Edward F Srour
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

2.  Target cells in bone for parathormone and calcitonin are different: enrichment for each cell type by sequential digestion of mouse calvaria and selective adhesion to polymeric surfaces.

Authors:  G L Wong; D V Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

3.  Human endothelial Pyk2 is expressed in two isoforms and associates with paxillin and p130Cas.

Authors:  Rosemary J Keogh; Rebecca A Houliston; Caroline P D Wheeler-Jones
Journal:  Biochem Biophys Res Commun       Date:  2002-02-08       Impact factor: 3.575

4.  Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2.

Authors:  T Ohmori; Y Yatomi; N Asazuma; K Satoh; Y Ozaki
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

5.  Connexin45 interacts with zonula occludens-1 and connexin43 in osteoblastic cells.

Authors:  J G Laing; R N Manley-Markowski; M Koval; R Civitelli; T H Steinberg
Journal:  J Biol Chem       Date:  2001-04-19       Impact factor: 5.157

6.  Mechanically strained cells of the osteoblast lineage organize their extracellular matrix through unique sites of alphavbeta3-integrin expression.

Authors:  M Wozniak; A Fausto; C P Carron; D M Meyer; K A Hruska
Journal:  J Bone Miner Res       Date:  2000-09       Impact factor: 6.741

7.  Targeting of PYK2 to focal adhesions as a cellular mechanism for convergence between integrins and G protein-coupled receptor signaling cascades.

Authors:  V Litvak; D Tian; Y D Shaul; S Lev
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

8.  Nuclear translocation of cell adhesion kinase beta/proline-rich tyrosine kinase 2.

Authors:  Hiroshi Aoto; Hiroko Sasaki; Masaho Ishino; Terukatsu Sasaki
Journal:  Cell Struct Funct       Date:  2002-02       Impact factor: 2.212

9.  Focal adhesion kinase suppresses Rho activity to promote focal adhesion turnover.

Authors:  X D Ren; W B Kiosses; D J Sieg; C A Otey; D D Schlaepfer; M A Schwartz
Journal:  J Cell Sci       Date:  2000-10       Impact factor: 5.285

10.  Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motility.

Authors:  A Sanjay; A Houghton; L Neff; E DiDomenico; C Bardelay; E Antoine; J Levy; J Gailit; D Bowtell; W C Horne; R Baron
Journal:  J Cell Biol       Date:  2001-01-08       Impact factor: 10.539

View more
  16 in total

1.  C-Mpl Is Expressed on Osteoblasts and Osteoclasts and Is Important in Regulating Skeletal Homeostasis.

Authors:  Tomas E Meijome; Jenna T B Ekwealor; R Adam Hooker; Ying-Hua Cheng; Wendy A Ciovacco; Sanjeev M Balamohan; Trishya L Srinivasan; Brahmananda R Chitteti; Pierre P Eleniste; Mark C Horowitz; Edward F Srour; Angela Bruzzaniti; Robyn K Fuchs; Melissa A Kacena
Journal:  J Cell Biochem       Date:  2015-10-06       Impact factor: 4.429

2.  Lnk Deficiency Leads to TPO-Mediated Osteoclastogenesis and Increased Bone Mass Phenotype.

Authors:  David J Olivos; Marta Alvarez; Ying-Hua Cheng; Richard Adam Hooker; Wendy A Ciovacco; Monique Bethel; Haley McGough; Christopher Yim; Brahmananda R Chitteti; Pierre P Eleniste; Mark C Horowitz; Edward F Srour; Angela Bruzzaniti; Robyn K Fuchs; Melissa A Kacena
Journal:  J Cell Biochem       Date:  2017-04-18       Impact factor: 4.429

3.  Pyk2 deficiency potentiates osteoblast differentiation and mineralizing activity in response to estrogen or raloxifene.

Authors:  Sumana Posritong; Jung Min Hong; Pierre P Eleniste; Patrick W McIntyre; Jennifer L Wu; Evan R Himes; Vruti Patel; Melissa A Kacena; Angela Bruzzaniti
Journal:  Mol Cell Endocrinol       Date:  2018-02-08       Impact factor: 4.102

4.  Osteomacs interact with megakaryocytes and osteoblasts to regulate murine hematopoietic stem cell function.

Authors:  Safa F Mohamad; Linlin Xu; Joydeep Ghosh; Paul J Childress; Irushi Abeysekera; Evan R Himes; Hao Wu; Marta B Alvarez; Korbin M Davis; Alexandra Aguilar-Perez; Jung Min Hong; Angela Bruzzaniti; Melissa A Kacena; Edward F Srour
Journal:  Blood Adv       Date:  2017-12-05

5.  Megakaryocyte and Osteoblast Interactions Modulate Bone Mass and Hematopoiesis.

Authors:  Marta B Alvarez; LinLin Xu; Paul J Childress; Kevin A Maupin; Safa F Mohamad; Brahmananda R Chitteti; Evan Himes; David J Olivos; Ying-Hua Cheng; Simon J Conway; Edward F Srour; Melissa A Kacena
Journal:  Stem Cells Dev       Date:  2018-05-15       Impact factor: 3.272

6.  A Pyk2 inhibitor incorporated into a PEGDA-gelatin hydrogel promotes osteoblast activity and mineral deposition.

Authors:  Sumana Posritong; Regina Flores Chavez; Tien-Min Gabriel Chu; Angela Bruzzaniti
Journal:  Biomed Mater       Date:  2019-02-27       Impact factor: 3.715

7.  A novel role for thrombopoietin in regulating osteoclast development in humans and mice.

Authors:  Monique Bethel; Calvin L T Barnes; Amanda F Taylor; Ying-Hua Cheng; Brahmananda R Chitteti; Mark C Horowitz; Angela Bruzzaniti; Edward F Srour; Melissa A Kacena
Journal:  J Cell Physiol       Date:  2015-09       Impact factor: 6.384

8.  Signaling pathways involved in megakaryocyte-mediated proliferation of osteoblast lineage cells.

Authors:  Ying-Hua Cheng; Drew A Streicher; David L Waning; Brahmananda R Chitteti; Rita Gerard-O'Riley; Mark C Horowitz; Joseph P Bidwell; Fredrick M Pavalko; Edward F Srour; Lindsey D Mayo; Melissa A Kacena
Journal:  J Cell Physiol       Date:  2015-03       Impact factor: 6.384

9.  Pyk2 regulates megakaryocyte-induced increases in osteoblast number and bone formation.

Authors:  Ying-Hua Cheng; R Adam Hooker; Khanh Nguyen; Rita Gerard-O'Riley; David L Waning; Brahmananda R Chitteti; Tomas E Meijome; Hui Lin Chua; Artur P Plett; Christie M Orschell; Edward F Srour; Lindsey D Mayo; Fredrick M Pavalko; Angela Bruzzaniti; Melissa A Kacena
Journal:  J Bone Miner Res       Date:  2013-06       Impact factor: 6.741

10.  Pyk2 and Megakaryocytes Regulate Osteoblast Differentiation and Migration Via Distinct and Overlapping Mechanisms.

Authors:  Pierre P Eleniste; Vruti Patel; Sumana Posritong; Odette Zero; Heather Largura; Ying-Hua Cheng; Evan R Himes; Matthew Hamilton; Jenna T B Ekwealor; Melissa A Kacena; Angela Bruzzaniti
Journal:  J Cell Biochem       Date:  2015-12-10       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.